Cargando…

Cyclo­oxygenase-1-selective inhibitor SC-560

In the title compound, 5-(4-chloro­phen­yl)-1-(4-methoxy­phen­yl)-3-(trifluoro­meth­yl)-1H-pyrazole (SC-560), C(17)H(12)ClF(3)N(2)O, a COX-1-selective inhibitor, the dihedral angles between the heterocycle and the chlorobenzene and methoxybenzene rings are 41.66 (6) and 43.08 (7)°, respectively. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Long, Sihui, Theiss, Kathryn L., Li, Tonglei, Loftin, Charles D.
Formato: Texto
Lenguaje:English
Publicado: International Union of Crystallography 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2968361/
https://www.ncbi.nlm.nih.gov/pubmed/21581958
http://dx.doi.org/10.1107/S1600536809001779
Descripción
Sumario:In the title compound, 5-(4-chloro­phen­yl)-1-(4-methoxy­phen­yl)-3-(trifluoro­meth­yl)-1H-pyrazole (SC-560), C(17)H(12)ClF(3)N(2)O, a COX-1-selective inhibitor, the dihedral angles between the heterocycle and the chlorobenzene and methoxybenzene rings are 41.66 (6) and 43.08 (7)°, respectively. The dihedral angle between the two phenyl rings is 59.94 (6)°. No classic hydrogen bonds are possible in the crystal, and intermolecular interactions must be mainly of the dispersion type. This information may aid the identification of dosage formulations with improved oral bioavailability.